bromodeoxyuridine has been researched along with Duncan Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ezine, S; Laouar, Y | 1 |
| Fundia, AF; Larripa, IB; Slavutsky, IR | 1 |
2 other study(ies) available for bromodeoxyuridine and Duncan Disease
| Article | Year |
|---|---|
In vivo CD4+ lymph node T cells from lpr mice generate CD4-CD8-B220+TCR-beta low cells.
Topics: Animals; Antigens, Surface; Bromodeoxyuridine; CD4-Positive T-Lymphocytes; Female; Flow Cytometry; Leukocyte Common Antigens; Lymph Nodes; Lymphocyte Activation; Lymphoproliferative Disorders; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Mice, Nude; Receptors, Antigen, T-Cell, alpha-beta; T-Lymphocyte Subsets | 1994 |
[Expression of new fragile sites detected in lymphoproliferative processes].
Topics: Bromodeoxyuridine; Chromosome Fragile Sites; Chromosome Fragility; Chromosomes, Human; Floxuridine; Humans; Lymphoproliferative Disorders | 1990 |